SCHEMBL7870296

SCHEMBL7870296

O=C1c2ccccc2C(=O)N1CCCCCn1c(=O)c2cccc3ncc1n32

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
USP2 O75604 1/20 0.47
TSHR P16473 1/20 0.47
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HTT P42858 2/20 0.42
MAPT P10636 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RAB9A P51151 1/20 0.41
HDAC8 Q9BY41 3/20 0.40
HDAC3 O15379 2/20 0.40
HDAC4 P56524 2/20 0.40
HDAC1 Q13547 2/20 0.40
HDAC7 Q8WUI4 2/20 0.40
HDAC2 Q92769 2/20 0.40
HDAC10 Q969S8 2/20 0.40
HDAC11 Q96DB2 2/20 0.40
HDAC6 Q9UBN7 2/20 0.40
HDAC9 Q9UKV0 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7863478 0.76 ALDH1A1 (0.48) ALDH1A1HPGDUSP2TSHRTDP1
SCHEMBL7870352 0.73 ALDH1A1 (0.45) ALDH1A1HPGDUSP2TSHRTDP1
SCHEMBL7863477 0.73 ALDH1A1 (0.45) ALDH1A1HPGDUSP2TSHRTDP1
SCHEMBL8862878 0.72 TDP1 (0.75) TDP1L3MBTL1HDAC8HDAC3HDAC4
SCHEMBL8863154 0.72 TDP1 (0.75) TDP1L3MBTL1HDAC8HDAC3HDAC4
SCHEMBL2604742 0.72 TDP1 (0.75) TDP1L3MBTL1HDAC8HDAC3HDAC4
SCHEMBL8863094 0.72 TDP1 (0.75) TDP1L3MBTL1HDAC8HDAC3HDAC4
SCHEMBL8862728 0.72 TDP1 (0.75) TDP1L3MBTL1HDAC8HDAC3HDAC4
SCHEMBL6777483 0.72 TDP1 (0.75) TDP1L3MBTL1HDAC8HDAC3HDAC4
SCHEMBL7863462 0.71 KMT2A (0.45) ALDH1A1HPGDUSP2TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010051631-A1 Tricyclic compounds, their production and use TAKATANI MUNEO (JP) 2001-12-13 US disclosed
US-6251905-B1 Tricyclic compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-06-26 US disclosed
EP-0771319-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1997-05-07 EP disclosed
WO-1996002542-A1 TRICYCLIC COMPOUNDS, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-02-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010051631-A1 Tricyclic compounds, their production and use PDGFA, HGF, REN ALDH1A1 2398/4885HPGD 1085/4885USP2 3432/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.